PASG vs TXT · $25.2M cap vs P/E 19, rev $7.52B
Passage Bio Inc (PASG) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Passage Bio Inc (PASG) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
PASG does not have a complete income-statement cache yet.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
PASG currently screens at market cap $25.2M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the PASG and TXT stock pages for the full models.
Not investment advice.